Overview
- 237 inspections across 202 sites are on record.
- 387 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-29.
At a glance
Inspections
237
Sites
202
Observations
387
Career since
Jun 2013
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Janssen Vaccines, Zweigniederlassung der Cilag GmbH International | 29 May 2026 | Biologics | On file |
| Novartis Pharma Stein AG | 19 May 2026 | Biologics | View 483 → |
| GSK Vaccines GmbH | 27 Feb 2026 | Biologics | On file |
| CSL Behring GmbH | 18 Feb 2026 | Biologics | View 483 → |
| Bioreliance Ltd. | 5 Dec 2025 | Biologics | On file |
Sites inspected
Janssen Vaccines, Zweigniederlassung der Cilag GmbH InternationalBern, Switzerland1 insp.
Novartis Pharma Stein AGStein Ag, Switzerland1 insp.
GSK Vaccines GmbHMarburg, Germany1 insp.
CSL Behring GmbHMarburg, Germany1 insp.
Bioreliance Ltd.Glasgow, United Kingdom1 insp.
Co-investigators
Investigators who share inspections with this person.
Brian M Campbell9 shared
Lewis K Antwi7 shared
Suyang Qin7 shared
Burnell M Henry5 shared
Thai D Truong5 shared
Melisa A Healy5 shared
Erma Zaimova5 shared
Brittany M Lowe4 shared
Kaarin M Slotte3 shared
Garrad R Poole3 shared
Full investigator report
Get the verbatim findings behind Travis S Bradley's 387 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site